Skip to content

Waldenström's Macroglobulinaemia

Waldenström’s macroglobulinaemia is a rare, slow-growing lymphoma that develops from abnormal white blood cells in the bone marrow. It belongs to a group of conditions called lymphoplasmacytic lymphomas.

Ibrutinib Capsules

Ibrutinib

140mg

Ibrutinib capsules for mantle cell lymphoma and chronic lymphocytic leukaemia. A targeted cancer medicine that blocks a specific protein driving the cancer.

From$23.83/ capsuleView

Key points

  • Waldenström’s macroglobulinaemia can cause fatigue, weakness, and repeated infections as abnormal proteins build up in the blood.
  • Treatment is not always needed at diagnosis; it begins when the disease causes symptoms or problems.

Medicines listed for Waldenström’s Macroglobulinaemia

The listed product is Ibrutinib Capsules, which contains the ingredient ibrutinib. Ibrutinib is a kinase inhibitor, a class of medicine that blocks signals causing abnormal cells to grow. Ibrutinib is the active ingredient represented in the catalogue for Waldenström’s macroglobulinaemia.

Further reading